Offer - Urjas Oil for just ₹ 1 X
Ebexid is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Ebexid safe for pregnant women?
Pregnant women can take Ebexid safely.
Is the use of Ebexid safe during breastfeeding?
Ebexid does not show any harmful effects in lactating women.
What is the effect of Ebexid on the Kidneys?
Very few cases of side effects of Ebexid on kidney have been reported.
What is the effect of Ebexid on the Liver?
You may experience side effects on your liver after taking Ebexid. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Ebexid on the Heart?
Side effects of Ebexid on heart are unknown because research on this has not been conducted yet.
Ebexid should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Ebexid unless your doctor advises you to do so -
Is this Ebexid habit forming or addictive?
Ebexid is not addictive in nature.
Interaction between Food and Ebexid
Some foods when eaten with Ebexid can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Ebexid
No research has been done on this till date. Therefore, it is not known what the effect of taking Ebexid with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Levoxyl (levothyroxine sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 769-770
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 900
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 914-915
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Niaspan® (niacin)